by Plus Therapeutics | Sep 18, 2024 | Uncategorized
Join us as Plus Therapeutics takes the stage at the @cns_update Annual Meeting, which will be held from September 28 through October 2, 2024, at the George R. Brown Convention Center in Houston, Texas. Presentation by John Floyd, M.D., Associate Professor and Chairman...
by Plus Therapeutics | Sep 13, 2024 | Uncategorized
Our clinical and patient coordination team was honored to be a part of patient and caregiver conversations at this month’s @HeadfortheCure support groups. We were so inspired to hear about everyone’s journeys and share how radiotherapeutic clinical trials...
by Plus Therapeutics | Sep 11, 2024 | Uncategorized
We would like to highlight our new Vice President of Regulatory and Quality Affairs, Navin Parwani. Plus Therapeutics is happy to have you on our team! ——————– Navin Parwani Vice President, Quality and Regulatory Affairs Navin...
by Plus Therapeutics | Sep 10, 2024 | Uncategorized
Another great @the_abta National Conference! 🎗️🧠 A huge thank you to their organization for hosting this event and to all the patients and caregivers who came by our booth to learn about our ongoing ReSPECT Clinical Trials. For more information, please visit:...
by Plus Therapeutics | Sep 7, 2024 | Uncategorized
Come by our booth today and tomorrow at @the_abta national conference in Chicago! Our clinical and patient advocacy team will be on-site to share educational material and answer your questions about our ReSPECT Clinical Trials. 🌟
by Plus Therapeutics | Sep 5, 2024 | Uncategorized
Join us at the @HeadfortheCure Patient Perspectives support group! We will discuss our ReSPECT-GBM clinical trial for Glioblastoma, patient resources, and upcoming events. Email courtney@headforthecure.org if you would like to attend.
Recent Comments